Home/Filings/4/0001140361-25-005660
4//SEC Filing

Flynn Sean C. 4

Accession 0001140361-25-005660

CIK 0000887359other

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 4:05 PM ET

Size

9.6 KB

Accession

0001140361-25-005660

Insider Transaction Report

Form 4
Period: 2025-02-20
Flynn Sean C.
Chief Legal Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-02-20+35,00035,000 total
    Exercise: $54.31Exp: 2035-02-20Common Stock (35,000 underlying)
  • Sale

    Common Stock

    2025-02-20$57.32/sh3,835$219,822756 total
  • Award

    Restricted Stock Unit

    2025-02-20+14,00014,000 total
    Common Stock (14,000 underlying)
Footnotes (6)
  • [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.
  • [F2]These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • [F3]These options shall begin vesting on February 20, 2025 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period.
  • [F4]Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation.
  • [F5]These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 20, 2026. The remaining RSUs will vest in annual installments on February 20, 2027, February 20, 2028, and February 20, 2029, respectively.
  • [F6]No expiration date for this type of award.

Issuer

Vericel Corp

CIK 0000887359

Entity typeother

Related Parties

1
  • filerCIK 0001801993

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 4:05 PM ET
Size
9.6 KB